The consultation is included in your monthly subscription
Insulin secretagogues: sulfonylureas They stimulate insulin secretion and are associated with a higher risk of severe hypoglycemia than metformin and other drugs in patients with advanced age and chronic liver or kidney disease.56 They do not modify IR and their effect may be limited in alcoholic individuals due to damage of the beta cells of pancreatic islets.57 Tolbutamide is not recommended in patients with liver disease since half-life increases over 50%.58 Glibenclamide (glyburide) and gliclazide are metabolized in the liver and eliminated through bile and kidney
Subsequently, Moore proposed the hypothesis that intestinal secretions might have a glycemic-lowering effect in diabetics, which was the first study to suggest an effect of intestinal secretions on blood glucose (Moore, 1906), and in the 1960s a team of researchers in the UK and the US independently discovered the incretin effect, in which oral glucose markedly stimulates insulin secretion, setting the stage for the subsequent development of incretin (Elrick et al., 1964
il y a 2 ans jadore ces produits me encantan estos productos ADRIAN F
Both can be relevant for vegan sports nutrition
(2023) GLP1-Employer Healthcare Thought Leadership
